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It  was  previously reported  that  ACTH  and  cortisone  in  combination  or 
cortisone  alone  produced  an  acceleration  of  poliomyelitis  infection  (strain 
MEF1)  in  mice  and  an  extraordinary enhancement  of  susceptibility to  this 
infection in Syrian hamsters giving rise to a violent and uniformly fatal disease. 
There was a significant increase in the titer of the virus in the brain of cortisone- 
treated  hamsters.  ACTH  alone  failed  to  produce  this  enhancement  (1,  2). 
Mice and hamsters receiving four intramuscular injections of 5 rag. of cortisone 
and inoculated with the virus intraperitoneally shortly after the second injec- 
tion  of cortisone showed  a  high mortality rate  with  about one-third  of mice 
and the majority of hamsters developing typical paralysis following an incuba- 
tion period of 4  to 17 days. The virus was recovered from the brain of animals 
paralyzed on the 5th and 17th day. All control mice and hamsters receiving no 
cortisone remained well following intraperitoneal  inoculation of the virus  I  (2). 
The experiments embodied in this paper serve to extend the observations on 
the  enhancing  effect  of  cortisone  upon  the  poliomyelitis infection  in  Syrian 
hamsters. 
Methods and Materials 
Strain MEF1 was supplied by Dr. Peter K. Olitsky and the Lansing strain by Dr. Albert 
Sabin. The strains were maintained by serial intracerebral mouse passages. Unless otherwise 
stated, Syrian male hamsters weighing 20 to 28 gin., supplied by Breeding  and Laboratory 
Institute, and Swiss male mice weighing 10 to 15 grn., strain CF1, obtained from Carworth 
Farms were used. All the animals were observed  daily for a  period of 4 weeks. The intra- 
cerebral inoculation  dose of the virus was 0.03 ml. for mice and 0.05 ml. for hamsters. The 
brain emulsions were diluted in saline. The individual brains and emulsions of large pools of 
brains were preserved in an electric refrigerator at --30°C. and in a dry-ice  chest. The neutral- 
ization tests for control identification of the strains and the neutralization experiments  de- 
scribed were carried out with an anti-Lansing monkey convalescent serum received from Dr. 
Hilary Koprowski. The authors are thankful to these investigators for making the materials 
available. 
* Aided by a grant from the National Foundation for Infantile Paralysis, Inc. 
In experiments now under progress  it has been possible  to obtain a  high  incidence  of 
ascending  prostrating paralysis following intramuscular injection of  Brunhilde strain into 
cortisone-treated rhesus monkeys.  The untreated monkeys showed no paralysis. 
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The hormones employed for the studies were made by the following manufacturers: adreno- 
corticotropic hormone,  lyophilized,  standard LA-1A (ACTH), ACTHAR, Armour Labora- 
tories; desoxycorticosterone  acetate (DCA)  5 mg. per ml. in sesame off, descorterone,  C. F. 
Kirk and Co.; progesterone,  5 mg. per ml. in sesame oil, progestin, Organon,  Inc.; diethyl- 
stilbestrol 1 rag. per ml. in peanut oil, Abbott; and cortisone acetate, cortone acetate, Merck 
and Co., 25 mg. per ml. The slow acting ACTH was prepared by dissolving lyophilized ACTH 
in warm 30 per cent gelatin containing 3 per cent procain, Armour Laboratories, Lot J  786, 
obtained through the courtesy of Dr. Irby Bunding.  DCA, progesterone,  diethylstilbestrol, 
and cortisone were injected into the thigh muscle in a volume not exceeding 0.2 ml. The right 
and left thigh were used alternately for repeated injections.  The ACTH and the slow acting 
ACTH were similarly injected intramuscularly, the largest volume for each injection being 
0.25 ml. and 0.3 ml. respectively. 
Enhancing Effect of Cortisone upon MEF1 Infection  in the Hamster 
Prior to and simultaneously with the experiments described below the toxic 
effect of cortisone was studied in 80 hamsters. 
Twenty hamsters received three injections of 5 nag. of cortisone over a period of 2 days. 
Eight animals  died 12 to 19 days following the third injection. There were no neurological 
symptoms, the animals showing milled fur,  diarrhea, and malnutrition a  few days prior to 
their death. No infections were seen on autopsy. The remaining 12 hamsters were in good 
condition although their growth was definitely delayed. Three groups of 20 hamsters received 
single injections of 2, 3, and 5 mg. of cortisone. Two animals of each group died between the 
3rd and 4th week following the treatment. The remaining 54 animals remained in good condi- 
tion. Growth seemed to be delayed in some animals receiving 5 rag. of cortisone for a period 
of 7 to 10 days. 
The purpose of the experiments recorded in Table I  was to find the minimal 
amount  of  cortisone  required  for  the  enhancement  and  to  determine  the 
minimal amount  of virus capable of eliciting the disease in  cortisone-treated 
hamsters.  Comparison of animals treated with various doses of cortisone and 
inoculated with virus diluted 1: 20 with the controls receiving the same amount 
of virus served to determine the smallest amount of cortisone necessary for the 
enhancement.  The controls which were divided into six groups of 10 and one 
group of 9  animals to accompany the experimental groups, showed a  range of 
mortality rates from  10 to 40 per cent with a  mean of 24.6 per cent.  In spite 
of the toxic effect of three injections of 5 mg. of cortisone recorded above, the 
enhancing effect of the drug upon poliomyelitis infection was readily observed 
since all the  animals died with pronounced  neurological symptoms following 
a  short  incubation period.  However,  the  relationship was  brought  out  more 
convincingly upon  examination of the  effect  of single injections of non-toxic 
or slightly toxic doses of the hormone.  Thus it was seen that a dose as small as 
2  rag.  of cortisone was  sufficient to produce an  unequivocal enhancement  of 
the disease as judged by a  mortality rate of 90 to 100  per cent in groups 5,  6, 
and 7 as compared to a mortality rate of 24.6 per cent in the control groups and 
insignificant late deaths with this amount of  cortisone in absence of the virus. GREGORY  SHWARTZMAN  AND  ALICE  FISHER  349 
The effect of 1 mg. of cortisone giving rise to 55.5  per cent  mortality rate in 
group 9  could be best considered  as  the end-point especially in view of the 
doubtful effect on the mean incubation period, to be discussed later. 
It may also be noted from Table I  that various intervals of time between 
cortisone and virus injections were employed in order to determine the optimum 
time-dosage relationship.  It  can be  concluded from these  observations  that 
single injections of 2  and 5  mg.  of cortisone given simultaneously, 2  and  18 
hours prior and  18 hours  after virus  inoculation were  capable of producing 
approximately the same increase in mortality rate provided a sufficiently high 
concentration of virus, namely, a dilution of 1:20 was employed. In contrast, 
while 5 mg. of cortisone was capable of raising the mortality rate to 77.8 per 
cent when administered  as long as 48 hours prior to the virus, a dose of 2 rag. 
failed to produce a  significant change in the mortality rate at this interval of 
time. 
In  the remaining  experiments animals  receiving 3  and  5  mg.  of cortisone 
were inoculated with various dilutions of virus at various intervals of time. 
When  given  simultaneously,  3  mg.  of  cortisone  increased  significantly  the 
mortality rate  following inoculation  of virus diluted  as  high  as  1:1000  and 
1:4000. On the other hand, 5 rag. of cortisone produced only a  moderate in- 
crease in mortality rate when injected 18 hours before, 18 hours after, and  2 
hours before the inoculation of the virus diluted 1 : 1000. The significance of this 
increa'se is doubtful since it is necessary to disregard the late deaths which in 
a small percentage of animals may be due to cortisone itself. Thus it is obvious 
that a  single small dose of cortisone may increase significantly the mortality 
rate following inoculation of a  highly diluted virus provided a  suitable  time 
interval between the cortisone and  virus injections is employed. 
In addition to increasing the mortality rate, cortisone was also responsible 
for shortening the mean survival time, deaths occurring within a range of days 
considerably narrower than in the control groups. A statistical analysis using 
the  Student's  t-test,  kindly  carried  out  by Dr.  Franklin  Hollander,  is  pre- 
sented in Table II. The P  value represents the difference between the mean 
survival time of the experimental groups and that of the corresponding controls. 
It is apparent from Tables I  and II that a  single injection of 2 and 5 mg. of 
cortisone given simultaneously,  2 and  18 hours prior and  18 hours following 
inoculation of virus diluted  1:20 resulted in a  highly significant reduction of 
the mean survival time. A dose of 5 rag. of the substance also shortened the 
mean survival  time when  injected as long as 46 hours prior to the virus.  It 
appeared that a  high mortality rate accompanied the reduction in the mean 
survival time to 5.6 to 7 days. The only exceptions were offered by groups 8 and 
12 of Table I, in which there were short survival time and a low mortality rate. 
However, the means derived from 3 and 4 animals, respectively, are statistically 
insignificant. In analyzing experimental results of this kind it would seem im- TABLE  I 
Titration  of Enhancing Effect of Cortisone in Hamsters 
Group No.  Treatment 
Cortisone 5 
rag. 3 X  4, 
19 hrs. 
Cortisone 5 
mg. 1  X 
Cortisone 2 
mg.  1  X 
Cortisone i 
mg.  1  X 
10  "  " 
MEFI 
Stock mouse passage  Total  NO. 
ani- 
Dilu-  Time  mals 
tion  Inoculated 
1:20  2 hrs. after  19 
1st cor- 
tisone 
1 : 20  Immedi-  10 
ately 
after 
corti- 
sone 
1:20  2 hrs. after  10 
corti- 
sone 
1 : 20  48 hrs.  9 
after 
corti- 
sone 
1:20  18 hrs.  10 
before 
corti- 
sone 
1: 20  Immedi-  10 
ately 
after 
corti- 
i  sone 
1:20  18 hrs.  10 
after 
corti- 
sone 
1:20  46 hrs.  10 
after 
corti- 
sone 
I : 20  Immedi-  9 
ately 
after 
corti- 
sone 
1:20  i  18 hrs.  I0 
after 
corti- 
,  sone 
Neurological  Death 
symptoms 
Days after  Days after 
inoculation  inoculation 
2,2,2,3,3,3,  4,4,5,'5,* 
3,3,4,5,5,  5,'5,'5,* 
5,5,5  6,6,6,6,6, 
6,6,6,6,6, 
6,7 
3,4,5,5,5,6,  4,*4,5,6,7, 
6,6,7  7,8,8,10, 
11 
2,2,3,3,3,3,3  3,6,6,6,6,7, 
3,6,6  7,7,7,8 
3,3,4,4,4,6,  4,'5,5,5,6, 
6  7,8 
2,5,5,5,5,5,  3,'5,'5,'5,* 
6  6,'6,7,8, 
8,19 
3,3,5,5,5,5,  5,5,5,'5,* 
5,'6,6,* 
7,7,9 
3,3,4,4,4,4,  3,'4,4,5,5,5, 
4,5  6,7,11 
3,3,5,6,6  4,6,8 
5,5,6,6,6,6,  6,6,8,9,20 
6,6,7 
2,4,5,5,6,6,  7,7,11 
7,8,8 
~ean  Mor- 
sur-  taIity  'ival 
:line  rate 
per 
~ay$  cerd 
5.6 100 
7.O 100 
6.3 100 
5.7  77.8 
7.2 100 
6.0 100 
5.6  90 
6.0  30 
9.8  55.5 
8.3  30 
* Died without neurological symptoms. 
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Group No. 
11 
12 
2ontrols 
for 1-12 
Treatment 
13 
MEFI  ]TI~  Neurological 
Stock mouse passage  1  symptons 
'  ani-i 
Dilu-  Time  mals i  Days after 
tion  inoculated  inoculation 
Cortisone O. 5  1: 20  Immedi- 
mg. 1  X  i  ately 
after 
corti- 
I  sone 
"  "  1:20  i  18 hrs. 
after 
corti- 
l  sone 
No treatment  1:20  i  D 
I 
i 
Cortisone 5  1:10001 18 hrs. 
mg. 1X  I  before 
corti- 
i  sone  ! 
9  5,5,6,6,7,7, 
12 
10  3,5,5,5,6,8, 
i  8 
69  2,2,3,3,3,3, 
3,3,4,4,4, 
4,5,5,5,5, 
5,5,5,6,6, 
7,7,7,8,8, 
8,8,9,9, 
i  12,12,13, 
[  13 
10  2,10,13 
Death 
Days after 
inoculation 
Meat  Mor- 
sur- 
vival  tality 
time  rate 
da~s  per 
cent 
8,9,13  10.0  33.3 
2,4,4,12  5.5  30 
3,*5,6,6,7,  11.6  24.~ 
8,8,8,10, 
12,13,13, 
14,17,21, 
21,25 
14 
15 
16 
~ontrols 
for 
13-16 
17 
18 
1:1000  2hrs. after  i  9  2,7,8,9 
corti- 
sone 
1:1000  18 hrs.  9  2,8,8,8,9,12 
[  after 
corti-  i 
i  sone 
Cortisone 3  1 : 1000  Immedi-  10  5,6,6,6,7,8 
mg. 1  X  ately 
after 
corti- 
sone 
No treatment  1:1000  --  20  5,6,6,10,12,20 
Cortisone 3  1:4000 i  Immedi-  10  3,3,6,6,6,8, 
mg. 1  >(  ]  ately  10,11 
]  after 
corti-  , 
l 
sone  I 
No treatment  1:40001  --  I 20  21 
6,6,*6,*6,*  7.8  50 
15 
4,'6,'15  8.3  33.~ 
6,'7,10,12,  10.8  55.~ 
19 
7,7,8,8,8,9,  8.1  80 
9,9 
12,14  13.0  10 
5,9,10,10,  11.9  100 
12,13,14, 
14,20 
14,20,22,23  19.5  20 
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portant,  therefore,  to  consider  as  significant  only those  results  in  which  the 
reduction  in  the  mean survival  time  is  accompanied by marked  rise  in  the 
mortality rate. 
Administration  of a  sufficient dose of cortisone also produced  a  change in 
the clinical course of poliomyelitis in the hamster. Several days after inocula- 
tion the animals showed conjunctivitis, ruffled fur, and arched backs. Neuro- 
logical  symptoms were  marked  and  tetraplegias  were  seen  much  more  fre- 
quently than in  the  control animals.  The incubation  period  for the  onset of 
paralysis was decidedly shortened,  ranging in most animals from 3  to 6 days, 
with the highest incidence of paralysis occurring 4 to 5 days following inocula- 
tion. These studies were followed by a long series of control experiments. 
TABLE  II 
Statistical Analysis  of Enhancement of Poliomyelitis Infection in Han~ters with the Aid 
of Cortisone 
N.. ............. 
Range  of  survival 
time, days  ...... 
Mean survival time, 
days ............ 
P value ........... 
Hamsters inoculated  intercerebraUy  with MEFI  diluted  1:20 
Controls receiv- 
ing no cortisone,ICortisone  5 rag. 
inoculated with  1 X  2 hrs.  prior 
the virus slmul-  to virus inocu- 
taneously with  I lation (group 3, 
the experlmen-  1  Table I) 
tal  groups 
4-25  3-8 
13.8  6.3 
O.O0O8 
Cortisone 2 mg. 
I X  18  hrs. 
prior  to  virus 
inoculation  ~a  OUp 7, 
ble I) 
3-11 
5.6 
O.OOO7 
Cortisone I  rn~ 
!I  X  immediate] 
[  prior  to  virus 
inoculation 
oup 9, 
ble I) 
6-20 
9.8 
0.19 
Cortisone  1 rag. 
I  X  18 hrs. 
prior to virus 
inoculation 
(group 10, 
Table I) 
10 
7-11 
8.3 
0.14 
Thirty-eight hamsters receiving cortisone were sacrificed 3 to 6 days follow- 
ing inoculation of the virus and all organs were cultured aerobically and anaero- 
bically. The brains of 3  animals showed Streptococcus viridans,  Staphylococcu~ 
aureus, and Staphylococcus albus. The livers and spleens of 6 animals were con- 
taminated with Escherichia coli and Streptococcus viridans.  The remaining cul- 
tures were sterile. It is apparent, therefore, that under the experimental con- 
ditions employed cortisone did not activate an inapparent bacterial disease in 
the hamster. 
In order to ascertain that the treatment with cortisone in the dosage used 
did not bring about an activation of some animal virus the following experi- 
ment was carried out: 
Twenty hamsters received one injection of 5 mg. of cortisone. 2 hours later 10 hamsters 
were injected intracerebrally with diluted broth  and the remaining animals were similarly 
injected with a mouse brain emulsion diluted 1:10 in rabbit serum. Two animals of the group 
injected with broth died without symptoms on the 12th day following intracerebral inocula- GREGORY  sH~rARTZMAN AND  ALICE FISHER  353 
tion and 18 animals remained in good condition.  In addition, 50 hamsters receiving one in- 
jection of 5 mg. of cortisone and an intracerebral inoculation of monkey cord or mouse brain 
emulsions  showed  no neurological  symptoms. Three animals died 6  to  28  days following 
inoculation.  The  experiments  demonstrated that  the  trauma resulting from intracerebral 
inoculation into hamsters treated with 5 mg. of cortisone did not activate any latent animal 
virus. 
In order to bring further support to the thesis that the enhanced disease ob- 
tained in cortisone-treated hamsters was caused by poliomyelitis virus a  neu- 
tralization experiment was performed, as follows: 
Mixtures of suitable dilutions of a titrated MEF1 mouse brain pool and anti-Lansing con- 
valescent serum were incubated in a water bath at 37°C. for 1 hour prior to intracerebral 
inoculation into cortisone-treated and non-treated hamsters.  The results are summarized in 
Table III. 
TABLE III 
Neutralization  of Poliomyelitis  Virus in Cortisone-Treated Hamsters 
Group  Treatment 
No. 
1 
2 
3  Cortisone  5  mg. 
I× 
4  "  " 
Anti- 
MEFI  Lansing  ~  ~, 
stock  ~oml 
monkey  N^ . 
mouse  convales-  . v. 
passage 
dilution  =ent serum ,anlmals 
dilution 
1  : 100  --  25 
"  1:10  15 
"  --  10 
"  1:10  15 
Neurological 
symptoms  Death 
Days after  Days after 
inoculation  inoculation 
9,10,10,11, 
14,18,21 
3,4,5,5,5,5, 
6 
15 
5,'13,18,19, 
19,22,'26" 
5,5 
4,*5,*6,6,6, 
6,7,11,11 
10,'16,'16, 
18" 
Mean 
snrviva 
time 
days 
17.5 
5.0 
6.9 
15.0 
Sor° 
tality 
rate 
28 
13.3 
90 
26.6 
* Died without neurological symptoms. 
As can be seen in the table, the virus in dilution used gave a  low mortality 
rate  after  a  prolonged  incubation  period.  The  neutralized  virus  inoculated 
into  untreated  hamsters gave no neurological symptoms and an insignificant 
death rate. The virus alone inoculated into cortisone-treated hamsters caused 
a  high mortality after a  short survival time, while the neutralized virus inocu- 
lated into similarly treated hamsters gave a  low mortality rate after a  mean 
survival time of  15  days. The experiments indicate that the poliomyelitis in- 
fection  can  be  neutralized  by  the  anti-Lansing  serum  in  cortisone-treated 
hamsters,  thus  clearly  establishing  again  the  enhancing  effect  of  cortisone 
upon the experimental poliomyelitis infection. 
All the facts thus far considered demonstrate beyond doubt that Cortisone 
produces  a  highly significant enhancement  of  experimental  poliomyelitis in- 
fection  in  the  hamster.  When  an  adequate  amount  of  cortisone is  used  the 
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severity of  symptoms,  marked  reduction  in  the  mean  survival  time,  and  an 
increase in the mortality rate to 100 per cent. 
Effect of Cortisone upon tke Concentration of MEF1 in the Hamster Brain 
Cortisone treatment of hamsters recorded in Table IV,  (pools III and IV)  consisted of 
three injections of 5 nag. each at intervals of 4 and 19 hours. Virus diluted 1:20 was inoculated 
intracerebrally 2 hours after the first cortisone injection. The brains were removed on the 1st 
day of marked paralysis, which appeared 4  to $ days following virus inoculation. Since the 
incidence of early paralysis was low in untreated hamsters, a  group of 15 animals was in- 
jected with virus diluted 1 : 20. The brains of 4 hamsters showing frank paralysis on the 5th 
and 6th days following inoculation were used for pool IL Brains of pool V were also removed 
on the 1st day of distinct paralysis appearing 5 to 6 days after virus inoculation. 
TABLE  IV 
Effect of Cortisone upon the Titer of MEF1 in the Brain of the Hamster 
Virus (MEFt) used for titration 
Pool I 
Stock mouse brain passage 
Pool II 
Brains of 4 hamsters infected with pool I 
Pool HI 
Brains of 3  cortisone-treated hamsters infected with 
pool I 
Pool IV 
Brains of 4  cortisone-treated hamsters infected with 
pool I 
Pool V 
Brains of hamsters infected with pool III 
LDsetiter 
In mice  In hamsters 
10--3.34  10---i  .~ 
10-1.~  l()--L06 
10--3.66  10-3 .u 
10  --a'e  n.d.* 
10  m m  10-1.44 
*n.d.  =  not determined. 
For the titrations, virus dilutions 1:10, 1:20, 1: 200, 1: 500, 1:1000, 1: 2000, 1:4000, 1 : 6000, 
and 1:8000 were inoculated intracerebrally into groups of 10 mice and 10 hamsters each. Pool 
I  contained 40 brains emulsified in the Waring blendor and preserved in a  dry-ice chest and 
electric refrigerator at -30°C. Repeated control titrations gave consistent results. The stock 
mouse virus and the experimental hamster virus were identified by failure to produce disease 
following intraperitoneal inoculation into mice and hamsters and by neutralization tests with 
anti-Lansing monkey convalescent serum. The virus-serum mixtures and virus dilutions were 
incubated in a water bath at 37°C. for 1 hour prior to intracerebrai inoculation. Ten mice were 
used for each serum dilution. The control virus dilutions gave 100 per cent mortality. 22 LD60 
of pool I were completely neutralized by serum diluted 1:1000, while 46 LDs0 of pool III were 
completely neutralized by serum diluted  1:200.  These results were in agreement with the 
neutralization titer obtained by Dr. Hilary Koprowski in his laboratory using the Lansing 
strain (3). 
In hamster titrations of MEFI with a  mouse LDs0 titer 10  ~.34 small numbers of deaths 
were obtained over a wide range of concentrations, dilution 1: 20 giving 10 to 40 per cent and GREGORY  SHWARTZMAN  AND  ALICE  FISHER  355 
dilutions 1:50, 1:100 and 1:500, 10 to 30 per cent mortality. Deaths with higher dilutions 
occurred very irregularly, thus making the findings of a sharp end-point somewhat difficult. 
Furthermore, when the cumulative method of Reed and Muench  is used in which it is assumed 
that animals dead at higher dilutions would have necessarily s~ccumbed at lower dilutions, 
the calculated LDs0 dose implies that the mortality rate obtained with dilution 1:20 is con- 
siderably higher than actually found upon testing in a large number of animals. The observa- 
tion seems to point to certain limitations of this statistical method when dealing with an 
animal species in which a virus shows an irregular effect over a protracted range of concen- 
trations. 
As can be seen from Table IV, consistently with partial refractoriness,  the 
concentration of the virus in the brain of hamsters receiving no cortisone was 
quite low, pool II showing a mouse titer 10  -1.~. A single passage through un- 
treated  hamsters  increased  the  titer  for  the  hamster,  pool  II giving in  the 
hamster  a  titer  three  times  greater  than  mouse  pool  I,  (10  --2.°5 vs.  10-1.~). 
Furthermore,  it  is  clearly established  that  the  concentration of the virus in 
cortisone-treated hamsters was significantly increased, the mouse titers of pools 
III and  IV being  107 and  135 times greater than the mouse titer of pool II. 
In  addition  the  virus  from  cortisone-treated  hamsters  yielded  in  untreated 
hamsters a titer which was 62 times greater than the mouse pool I and 20 times 
greater than pool II derived from untreated hamsters.  The observation sug- 
gests that in addition to increasing the concentration, cortisone may also be 
responsible for an increase in the virulence of the virus for the hamster, which 
is more significant than  that obtained by a  single passage through hamsters 
receiving no cortisone. On the other hand, since there was a twofold increase in 
the titer of the virus for the mouse (pool IIIrs. pool I) and a threefold increase 
due  to a  single passage through untreated hamsters  (pool II vs. pool I), the 
increase in virulence of the virus derived from cortisone-treated hamsters for 
untreated hamsters may be in reality the added effect of both the increase in 
virus concentration and the adaptation-which may or may not be facilitated 
b y cortisone. Whatever the reasons for the effect it is also clear that the greater 
potency of the virus obtained from the cortisone-treated hamsters is not main- 
tained  on further passage through hamsters receiving no cortisone  (pool V). 
Effect of Cortisone upon Infection  with MEF1 and Lansing  Strains it~ Hamsters 
from Various Breeders 
The studies thus far described were carried out with strain MEF1 in hamsters 
obtained  from  the  same  breeder  (i.e.,  Breeding  and  Laboratory Institute). 
The purpose of the work about to be reported was to compare the effect of 
cortisone  upon  infection  with  the  Lansing  strain  in  the  hamsters  from  the 
above breeder and also to determine the effect of the hormone upon infection 
with both strains  in hamsters obtained from other breeders.  The results  are 
summarized in Table V. Interpretation of the observations recorded in this table 
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However, differences in susceptibility to poliomyelitis infection are shown by a 
definitely higher resistance of hamsters from one breeder, (Seaman vs. Lakeview 
and Breeding and Laboratory Institute). Differences in resistance to the infec- 
tion in hamsters from different breeders were previously recorded by Stebbins 
and Lensen (3). Consistently, the effect of cortisone seemed to parallel these 
differences in the sense that a larger amount of virus was required to bring out 
"FABLE V 
The Effect of Cortisone upon MEF1 and Lansing Infection  in Hamsters from  Various Breeders 
i 
Group  Treatment 
No. 
Strain  Dilu- 
tion 
1  Cortisone  MEF1  1:100 
5mg. 
1X 
2 
3  Cortisone  "  " 
5mg. 
tX 
4 
5  Cortisone  "  1:20 
5 rag. 
iX 
6 
7  Cortisone  "  1:100 
5 rag. 
1X 
8 
I0 
II  Cortisone 
5 mg. 
1X 
12 
Cortisone  Lansing  " 
5 rag.  (Sabln, 
Pool  VI) 
Poliomyelitis virus  Neurological  Death  Mean  Mor 
stock mouse passage  Total  symptoms 
No.  Breeder  sur-  • " 
ani-  ~.  vael  rt~a~ 
Time  reals  Days after  Days after 
inoculated  inoculation  inoculation 
days  per 
cent 
Simultane-  10  Breeding &  3,4,5,5,5,5,6  4,'5,6,6,6,6,*  6.9  90 
ously  with  Laboratory  7,11,11 
cortisone  Institute 
--  10  "  "  5,10,11,12,13  4,17,19  13.3  30 
Simultane-  13  Lakeview  1,5,5,5,6,6,6,  5,5,6,6,6,7,7,  7.2  100 
ously with  6,6,6  7, 7, 8,10, 
cortisone  I0,I0 
--  10  "  7,10,12  --  --  0 
Simultane-  9  Seaman  3,5,5,5,7,9  3,'3,'5,'5,6,  7.0  100 
ously with  8, 12, 15 
cortisone 
--  9  "  5,12,12,16  --  --  0 
.Simultane-  18  "  L6,8,8,8,8,9,  3,6,6,8,9,9  6.8  33.3 
ously with  9,9,9,22 
cortisone 
--  18  ~  5,9,9,12,16,20,  10,28  14.0  11.1 
27,27~27,27 
Simultane-  10  Breeding &  5,6,7,7,7,14  6,7,'7,8,'8,8,  7.7  90 
ously with  Laboratory  8,9,'9 
cortisone  Institute 
--  10  "  "  5,6,7,8,20  10,12,12  11.3  30 
Simultane-  10  Seaman  8,13,13  --  --  0 
ously with 
cor  tiso'ae 
--  10  "  --  --  --  0 
* Died without neurological symptoms. 
the enhancing effect of cortisone in the more resistant hamsters. Thus, Seaman 
hamsters  treated  with  cortisone  all  succumbed  to  inoculation  with  MEF1 
diluted  1:20, while the non-treated controls all resisted the infection. In con- 
trast, when a  dilution 1:100 was used the difference between the treated and 
non-treated  animals  was  of  lesser  significance.  Furthermore,  although  the 
behavior of Lansing and MEF1 strains was similar under the influence of corti- 
sone in the more susceptible hamsters  (groups 1, 2, vs. 9,  10),  cortisone failed 
to influence altogether the course of the infection with the Lansing strain in 
the more resistant hamsters (groups 11 and 12). TABLE VI 
Effect of Various Hormones upon Poliomyelitis in Hamsters 
Group  No__  Treatment 
MEF1  Neurological 
Stock mouse passage  No.  symptoms  Total 
-  anl- 
Dilu-  Time  reals  Days after 
fion  inoculated  inoculation 
Cortisone 5  1:20  2 hrs.  after  10  5,5,5,5,5 
mg. 3  X  4,  Ist corti- 
19 hrs.  sone 
Cortisone 5  1:20  2hrs. after  10  2,2,3,3,3,3, 
mg. 1 X  cortisone  3,3,6,6 
ACTH 5  mg.  1:20  2 hrs.  after  9  3,6,6 
10 
Controls 
for 1-1C 
3  X  4,  19 
hrs. 
ACTH3  mg.  i:20 
5  )<  4,  19, 
24, 24 hrs. 
ACTH in gel-  1 : 20 
atin 10 mg. 
2  X  24 hrs. 
DCA  1  rag.  1:20 
1× 
DCA  1  mg.  1:20 
3  ×  18,  4 
hrs. 
DCA  1  mg.  1:20 
3  ×  18,  4, 
18 hrs. 
Cortisone 5 
mg. 3  X  4, 
18 hrs. 
Progesterone  1:20 
0.25 mg. 
i  3  X  24,  24 
hrs. 
Diethylstil-  1 : 20 
bestrol 0.25 
mg. 3 X 24, 
24 hrs. 
No treatment  1:20 
1st ACTH] 
2 hrs.  after  9  4,4,7,9 
1st ACTH 
2 hrs.  after  10  3,5,6,8,14 
1st ACTH 
]/~ hr. after  10  8,8 
DCA 
22hrs. after  8  5,9,11,12 
3rd DCA 
2 hrs.  after  I 10  1,1,1,1,1,1, 
I 
1st  corti-  [  5,5 
sone  ] 
Immediately  10  5,14,22 
after 2nd 
progest- 
erone 
Immediately  10  4,4,7 
after 2nd  i 
stilbestrol i 
-  150 
I 
I 
11 
Control 
for 11 
ACTH 5  mg.  1:I00  3  hrs.  after 
1 X  ACTH 
Cortisone 5 
mg. 2  X  5, 
19 hrs.  J 
No treatment  1 : 100 
10 
10 
3,4,4,4,5,5, 
6,6,6,6,6, 
7,7,7,7,7, 
7,8,8,9,9, 
9,12,14, 
19,19 
2,2,2,2,3,3, 
3,3,3,3 
6,6,6,7,9,20 
Deaths 
Days after 
inoculation 
Mean[  Mor- 
sur- 
vlval  tality 
time  Rate 
days  per 
cent 
5,'5,'5,'5,*  5.~ 100 
5,'6,6,6, 
6,7. 
3,6,6,6,6,7,  6.3  100 
7,7,7,8 
6,10  8.0  22,~ 
7,7  7.0  22.~ 
6,26  16.0  20 
11,15,16,20  15.5  50 
i,'2,2,5,5, 
5,*6,6,7, 
7 
5.8 100 
25.0  10  25 
19,19  19.0  20 
8.3  18  4,*5,6,7,9, 
9,10,14, 
19 
4,6,6,6,6,6,  6.6 100 
6,7,9,10 
15,21  18.C  20 
* Died without neurological symptoms. 
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Effect  of Hormones  Other than Cortisone upon the Susceptibility of the Hamster 
to Experimental Poliomyelitis 
The results of these experiments are  summarized  in  Table VI.  As can be 
seen from this table, various hormones other than cortisone produced no effect 
upon the susceptibility of the hamster to poliomyelitis under the experimental 
conditions described.  It is of  particular  interest  that  ACTH  did  not  alter 
the resistance of the animal to the infection following repeated injections of 
very  large  doses,  including  the  slow  acting  gelatin  preparation.  ACTH 
failed,  however,  to  oppose  the  enhancing  effect of cortisone when  the  hor- 
mones were administered together. 
DISCUSSION  AND  CONCLUSIONS 
The enhancing effect of cortisone upon certain reactions to toxins (4) and in 
particular, the fact that pregnant women in whom there is a greatly increased 
adrenocortical function  (5)  show  a  relatively high incidence of poliomyelitis 
(6)  suggested  the  investigation of the effect of cortisone upon  experimental 
poliomyelitis. Since an enhancement of the infection under the influence of the 
hormone  was  anticipated,  an  animal  partially  refractory to  the  virus,  the 
Syrian hamster, was selected for these studies (1, 2). The data embodied in this 
paper serve to extend the initial  observations as  follows: 
Cortisone in non-toxic doses is capable of producing an unequivocal enhance- 
ment of experimental poliomyelitis in the Syrian hamster. When an adequate 
amount of cortisone is used the enhancement manifests itself in shortening of 
the incubation period,  increased  severity of symptoms, marked  reduction in 
the mean survival time, and an increase in the mortality rate. The duration 
of the enhancing effect of the hormone is protracted depending on the dose 
employed. There is a definite reciprocal relationship between the dose of corti- 
sone producing the enhancement and the concentration of the virus, the larger 
the dose of cortisone used, the smaller the amount of virus being necessary to 
elicit the infection. 
The accompanying control studies prove that under the experimental condi- 
tions employed the effect of cortisone observed is not confused with an  en- 
hancement  of  some  latent  bacterial  or  viral  infection.  The  identity of  the 
disease elicited is established by neutralization tests in mice of the virus re- 
covered from the brains of cortisone-treated hamsters with the anti-Lansing 
convalescent monkey serum and finally by the neutralization of the virus with 
the serum in cortisone-treated hamsters. 
It is  noteworthy that  there is an  increase of approximately 2  logs in  the 
concentration  of  the  virus  in  the  brain  of  cortisone-treated hamsters.  The 
greater potency of the virus obtained from the cortisone-treated hamsters is 
not maintained on further passage through non-treated hamsters. It seems of 
interest  to  determine  whether  in  clinical  poliomyelitis there may be  an  in- GREGORY  SHWARTZMAN  AND  ALICE  FISHER  359 
creased amount of virus carried by patients in certain states of endocrine im- 
balance, pregnancy in particular. 
Some suggestive evidence is reported on possible differences in the response of 
different hamster  breeds to the enhancing  effect of cortisone,  the  difference 
appearing to be more pronounced with the Lansing than with the MEF1 strain. 
Hormones other than cortisone  (DCA, progesterone, and diethylstilbestrol) 
and fast and slow acting ACTH injected repeatedly and in large doses fail to 
modify the poliomyelitis infection in the hamster. The possibility needing fur- 
ther examination suggests itself that in addition to cortisone,  ACTH may stim- 
ulate  the  production  of some unknown  factor  capable  of reversing  the  en- 
hancing  effect of cortisone.  The  findings  on the failure of ACTH to modify 
the  experimental  infection  are  consistent  with  the  observations  of  Coriell, 
Siegal, Cook, Murphy, and Stokes (7) on the lack of effect of the hormone upon 
clinical  poliomyelitis and those of Ainslie,  Francis, and Brown (8) and Milzer 
(9) concerned with the negative effect in mice. However, according to Ainslie, 
Francis, and Brown (8), ACTH produces a slight acceleration of the onset of 
paralysis in monkeys inoculated with the Minnesota strain  and according to 
Foster, Sigel, Henle, and Stokes (10) a relatively higher incidence  of paralysis 
following  inoculation  of the Yale  SK strain  into  a  small group of monkeys. 
Recently Sabin (11) confirmed  the findings  reported by one of the authors of 
this paper  (1, 2) on the effect of cortisone upon poliomyelitis infection in the 
hamster using the Lansing strain and  also found that in monkeys inoculated 
with strains of low virulence cortisone is able to convert the non-paralytic and 
mildly paralytic infections to severe prostrating  paralysis. 
The  possible  hormonal  influences  upon  poliomyelitis  in  man  have  been 
pointed  out in  the past  (12).  Although  many previous experimental  studies 
using different hormones were either negative or equivocal, the results of Aycock 
were indicative in this direction since they showed an increase in resistance to 
nasal  instillation  of poliomyelitis virus in  castrated  female monkeys treated 
with estrin (13). 
When considered in the light of the effect of cortisone recorded in this paper, 
a number of previous observations, seemingly unrelated,  dealing with altera- 
tion in predisposition to clinical  and experimental poliomyelitis may have one 
common  denominator,  a  possible  temporary  disturbance  in  adrenocortical 
function, with a resulting hypersecretion of cortisone and  therefore merit re- 
examination from this point of view, namely: increased susceptibility due to 
excessive fatigue in monkeys (14) and man (15), surgical procedures and trauma 
in man and monkeys (16), pregnancy in women (6) and mice (17), prophylactic 
vaccination in man  (18),  and injection of T.A.B.  and pertussis vaccines and 
diphtheria toxoid in mice (19). 
The fast accumulating body of information points to the fact that the en- 
hancing effect of cortisone may not be limited to poliomyelitis. Shortly after 360  EFFECT OF CORTISONE ON POLIOMYELITIS INFECTION 
publication of the initial observations in connection with poliomyelitis (1,  2) 
a number of authors reported an acceleration of different viral diseases with the 
aid of cortisone and in some instances also with ACTH. Kilborne and Horsfall 
demonstrated an augmented multiplication of influenza A and B and mumps 
viruses in  chick  embryos injected with cortisone  (20) and also succeeded in 
obtaining a fatal Coxsackie disease in cortisone-treated adult mice (21). Loosli, 
Hull, Berlin, and Alexander (22) obtained an increase in the mortality rate from 
air-borne influenza virus in mice receiving ACTH, although there was no al- 
teration in the gross and microscopic findings and in the rate of growth of the 
virus.  On the other hand, the hormone had no effect upon this infection in 
ferrets  (23).  It also failed to modify the course of the influenza infection in 
mice inoculated intranasally, while cortisone treatment increased the mortality 
rate  (24).  According  to  Kalter,  Smolin,  McElhaney,  and  Tepperman  (25) 
treatment of mice with ACTH and cortisone caused some depression of mul- 
tiplication of influenza virus in mice. Primary infection and reinfection with 
vaccinia virus were found to be more severe and the healing slower in cortisone- 
treated than untreated guinea pigs  (26).  Cortisone was also reported  to in- 
crease the mortality rate of mice infected with Japanese B  encephalitis (27). 
ACTH was ineffective in Western equine encephalomyelitis (28).3 This hormone 
and  cortisone  were  without effect upon  rickettsial  infection  in  mice  (30). 
According to Southam and Babcock (31)  large doses of cortisone greatly in- 
creased the susceptibility of mice to lethal infection by West Nile, Rheus, and 
Bunyamwera viruses. ACTH in massive dosage produced the same effect with 
West Nile virus. 
Comparison between the effects of ACTH and cortisone upon poliomyelitis 
with other virus diseases is very difficult at this time in view of the wide di- 
vergence of experimental conditions, namely, animal species,  time of admin- 
istration of the hormones, dosage of the hormones, routes used for injection of 
viruses, etc. Furthermore, since the hormones have many physiological activi- 
ties it cannot be assumed that the mechanisms involved in acceleration of in- 
fections with viruses widely different from one another are necessarily the same. 
SUM~.ARY 
Cortisone produces a  significant enhancement of infection with MEF1 and 
Lansing strains of poliomyelitis virus in the Syrian hamster. The enhancement 
manifests itself in increased severity of symptoms, shortening of the incubation 
period, marked reduction in survival time and a  high mortality rate. 
The effect of cortisone is protracted,  the  duration depending on  the dose 
used. There is a reciprocal relationship between the dose of cortisone and the 
2 It is of interest in this connection that according to Hodes (29) pregnancy interferes with 
development of acquired  immunity and  diminishes a  previously established  immunity in 
mice to St. Louis encephalitis. GREGORY  SHV~ART~AN  AND ALICE ]~ISHER  361 
amount of virus, the larger the dose of the hormone, the smaller the amount of 
virus being necessary to produce the infection. An amount of virus of low in- 
fectivity causes a  marked disease with a  high mortality rate in hamsters re- 
ceiving a single injection of 3 mg. of cortisone, while a dose as small as 2 mg. 
gives a highly fatal disease with a  stronger concentration of the virus. 
There is a 2 log increase in the concentration of the virus in cortisone-treated 
hamsters. 
Hamsters from various sources seem to respond differently to the enhancing 
effect of cortisone, one breed showing no enhancement of the infection with the 
Lansing strain. 
Hormones other than cortisone, i.e., DCA, progesterone, diethylstilbestrol, 
and fast and slow acting ACTH injected repeatedly fail to modify the polio- 
myelitis infection in the hamster. 
The authors wish  to acknowledge  thankfully  the capable  assistance  of Miss  Doreen  Hollings 
and Miss Louise  Leonard. 
BIBLIOGRAPHY 
1.  Shwartzman, G., Proc. Soc. Exp. Biol. and Meal., 1950, "/5, 835. 
2.  Shwartzman,  G., Am. J. Path.,  1951, 27, 714, (abstract). 
3.  Stebbins, M. R., and Lensen S. G., Proc. Soc. Exp. Biol. and Med., 1949, 71, 272. 
4.  Thomas, L. and Mogabgab, W. J., Proc. Soc. Exp. Biol. and Med., 1950, 74, 829. 
5.  Venning, E. H., Endocrinology, 1946, 39, 203. 
6.  McGoogan, L. S., Am. J. Obst., 1932, 24, 215. Aycock, W. L., New England J. 
Med., 1941, 29.5, 405; 1946, 9.36, 160, and others. 
7.  Coriell, L. L., Siegel, A. C., Cook, C. D., Murphy, L., and Stokes, J. Jr., f. Am. 
Med. Assn., 1950, 142, 1279. 
8.  Ainslie, J. D, Francis, T. Jr., and Brown, G. C., J. Lab. and Clin. Med., 1951, 38, 
344. 
9.  Milzer, A., J. Infect. Dis.,  1951, 88, 54. 
10.  Foster,  C., Sigel, M. M., Henle, W., and Stokes, J. Jr., J. Lab. and Clin. Med., 
38, 359. 
11.  Sabin, A., Reported at the Conference on Viruses as Causative Agents in Cancer, 
November  16, 1951, New York Academy of Sciences. 
12.  Jungeblut, C. W., and Engle, E. T., J. Exp. Meal., 1934, 59, 43. Aycock, W. L., 
Endocrinology, 1940, 27, 49. 
13.  Aycock, W. L., Proc. Soc. Exp. Biol. and Med.,  1936, 34, 573. 
14.  Levinson, S. O., Milzer, A., Lewin, P., Am. J. Hyg., 1945, 42, 204. 
15.  Russel, W. R., Brit. Meal. J., 1947, 2, 1023. Horstman, D. M., f . Am. Meal. Assn., 
1950, 142, 236. 
16.  Aycock, W. L., Medicine,  1942, 21, 65. Francis, T., Jr., Krill, C. E., Toomey, J. 
A., and Mack, W. N., J. Am. Med. Assn., 1942, 119, 1392, Harrington, A. B., 
Lancet,  1951, 1, 987. Faber,  H. K., McNaught, R. C., Silverberg, R. J., and 
Dong, L., Proc. Soc. Exp. Biol. and Med.,  1951, 77, 532. von Magnus, H., and 
Melnick, J. L., Am. J. Hyg.,  1948, 48, 113. 362  EFFECT OF CORTISONE  ON  POLIOMYELITIS  INFECTION 
17.  Byrd, C. L., J. Neuropath. and Exp. Neurol.,  1950, 9, 202. Knox, L., Proc. Soc. 
Exp. Biol. and Med.,  1950, 72, 520. 
18.  Martin, J. K., Arch. Dis. Childhood, 1950, 9.5, 1. McCloskey, B. P., Lancet, 1950, 
1,659. Geffen, D. B., Meal. Off., London, 1950, 83, 137. Hill, A. B., and Knowel- 
den, J., Brit.  Meal. J., 1950, 2, 1. Goerke, L. S., California J. Med.,  1951, 74, 
383. Anderson, G. W., and Skaar, A. E., Bull.  Univ. Minn. Hosp. and Minn. 
Med. Found.,  1951, 9.2, 359. 
19.  Findlay, G. M., and Howard, E. M., J. Path. and Bact., 1950, 62, 371. Milzer, A., 
Weiss, M. A., and Vanderboom, K., Proc. Soc. Exp. Biol. and Meal., 1951, 77, 
485. 
20.  Kilborne, E. D., and Horsfall, F. L., Jr., Proc. Soc. Exp. Biol.  and Meal., 1951, 
76, 116. 
21.  Kilbome, E. D., and Horsfall, F. L., Jr., Proc. Soc. Exp. Biol. and Meal., 1951, 77, 
135. 
22.  Loosli, C. G., Hull, R. B., Berlin, B. S., and Alexander, E. R., J. Lab. and Clin. 
Meal., 1951, 37, 464. 
23.  Hull, R. B., and Loosli, C. G., J. Lab. and Clin. Meal., 1951, 37, 603. 
24.  Kass, E. H., Ingbar, S. H., Lundgren, M. M., and Finland, M., J. Lab. and Clin. 
Med. 1951, 37, 780. 
25.  Kalter, S.  S., Smolin, H. I., McElhaney,  I. M., Tepperman,  I., J. Exp. Med., 
1951, 93,529. 
26.  Kligman, A. M., Baldridge, G. D., Rebell, G., and Pillsbury, D. M., J. Lab. and 
Clin. Meal., 1951, 37, 615. 
27.  Vollmer, E. P., and Hurtbut, H. S., J. Infect. Dis.,  1951, 89, 103. 
28.  Milzer, A., J. Infect. Dis.,  1951, 88, 54. 
29. Hodes, H. L., J. Exp. Med.,  1939, 69, 533. 
30.  Jackson,  E. B., and Smadel, J. E., Bact. Proc., 1950, 92. 
31.  Southam, C. M., and Babcock, V. I., Proc. Soc. Exp. Biol. and Meal., 1951, 78, 105. 